Page last updated: 2024-10-25

cimetidine and Cancer of Salivary Gland

cimetidine has been researched along with Cancer of Salivary Gland in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, M2
Kusama, K2
Sakashita, H2
Tanaka, S1
Suzuki, S1
Kaneko, T1

Other Studies

2 other studies available for cimetidine and Cancer of Salivary Gland

ArticleYear
Cimetidine inhibits salivary gland tumor cell adhesion to neural cells and induces apoptosis by blocking NCAM expression.
    BMC cancer, 2008, Dec-18, Volume: 8

    Topics: Animals; Apoptosis; Cell Adhesion; Cimetidine; Dose-Response Relationship, Drug; Down-Regulation; Ge

2008
Cimetidine induces apoptosis of human salivary gland tumor cells.
    Oncology reports, 2007, Volume: 17, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cimetidin

2007